Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients

Study acronym: DICAM
StatusCompleted
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 0 to 1v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Active, Not Recruiting to Completedv3 Show 8 more changesShow less
    • Primary completion date: Nov 2006
    • Study completion date: Jun 2006 to Nov 2006
    • Interventions: ciclosporine A (Drug) to cyclosporine A (Drug)
    • Eligibility criteria revised
    • Secondary endpoints revised (15)
    • Study description expanded, about 594 words
    • Study title revised
    • Study arms: 0 to 2
  4. Study completion date: Jun 2006v2
  5. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to show the efficacy of reduction of cyclosporine A exposure measured by the area under the curve by Bayesian estimator on the primary prevention of degradation of the renal function in renal transplant recipients
Trial Details
NCT Number NCT00213590
Lead Sponsor University Hospital, Rouen
Conditions
(from sponsor)		 Kidney Transplantation, Primary Prevention, Kidney Failure
Related terms Renal Insufficiency
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov